Simvastatin
Product Images NDC 60760-006

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Simvastatin (NDC 60760-006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St Marys Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Simvastatin 60760 005 30 5.13

Simvastatin Tablets USP 20mg label showing a quantity of 30 tablets. The label includes the NDC number 60760-005-30 and indicates it is manufactured by Intas Pharmaceuticals Limited, Ahmedabad, India, and packaged by St. Mary's in Oro Valley, AZ. Additional text includes a storage instruction to store at controlled room temperature between 15°-30°C (59°-86°F).*

FDA Label Image

Simvastatin 60760 006 30 5.13

Simvastatin 40 mg tablets USP packaging label shows quantity of 30 tablets. Label includes NDC 60760-006-30, Rx number placeholder, lot number and expiration date placeholders. Manufactured by Intas Pharmaceuticals Limited in India and packaged by St Mary's Pharmacy in Oro Valley, AZ. Instructions indicate use as directed and storage at controlled room temperature 15°-30°C (59°-86°F). A barcode and QR code are also present.*

FDA Label Image

Simvastatin 60760 019 30

SIMVASTATIN Tablets USP 80 mg packaging label showing a quantity of 30 tablets. The label includes the National Drug Code (NDC) 60760-019-30 and indicates the product is manufactured by Intas Pharmaceuticals Limited, Ahmedabad, India, and packaged by St. Mary's, Oro Valley, Arizona. Directions state to 'Use as directed' and to store at controlled room temperature between 15°-30°C (59°-86°F). The label also includes a barcode and QR code.*

FDA Label Image

Simvastatin (Simvastatin 1)

Chemical structure of the active ingredient Simvastatin showing its multi-ring lactone form with multiple methyl and hydroxy groups visible.*

FDA Label Image

Simvastatin (Simvastatin 2)

A comparative risk ratio chart showing incidence percentages and risk ratios for major vascular and major coronary events among various patient subgroups taking Simvastatin tablets versus placebo. The chart includes baseline characteristics such as diabetes status, gender, age, and cholesterol levels, with confidence intervals and risk favoring either Simvastatin or placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.